Older primary care patients' willingness to consider discontinuation of chronic benzodiazepines

General Hospital Psychiatry

Volumn 29, Issue 5, 2007, Pages 396-401

  Cook, Joan M ^a,b   Biyanova, Tatyana ^a,b   Thompson, Richard ^c,d   Coyne, James C ^e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Juvenile Protective Association   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anxiety; Anxiolytic; Benzodiazepine; Discontinuation

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ADULT; AGED; ANXIETY DISORDER; ANXIETY SENSITIVITY INDEX; ARTICLE; BECK ANXIETY INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL ARTICLE; DRUG WITHDRAWAL; FEMALE; GERIATRIC PATIENT; HUMAN; LONG TERM CARE; MALE; PATIENT ATTITUDE; PITTSBURGH SLEEP QUALITY INDEX; QUESTIONNAIRE; RATING SCALE; SEMI STRUCTURED INTERVIEW; SEVERITY OF DEPENDENCE SCALE;

AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; BENZODIAZEPINES; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PENNSYLVANIA; PRIMARY HEALTH CARE; QUESTIONNAIRES;

EID: 34548628716     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2007.07.001     Document Type: Article

References (37)

1. Hanlon J.T., Horner R.D., Schmader K.E., et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 64 (1998) 684-692
2. Hemmelgarn B., Suissa S., Huang A., Boivin J.F., and Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278 (1997) 27-31
3. Pomara N., Tun H., DaSilva D., et al. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: Relationship to duration of treatment and self-rated sedation. Psychopharmacol Bull 34 (1998) 139-153
4. Ried L.D., Johnson R.E., and Gettman D.A. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc 46 (1998) 71-76
5. Wang P.S., Bohn R.L., Glynn R.J., Mogun H., and Avorn J. Hazardous benzodiazepine regimens in the elderly: Effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 158 (2001) 892-898
6. American Psychiatric Association Task Force on Benzodiazepine Dependency. Benzodiazepine dependence, toxicity, and abuse (1990), Author, Washington (DC)
7. NIH Consensus Development Conference. Drugs and insomnia: The use of medications to promote sleep. JAMA 251 (1984) 2410-2414
8. Llorente M.D., David S., Golden A.G., and Silverman M.A. Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatry Neurol 13 (2000) 150-160
9. Cook J.M., Biyanova T., Masci C., and Coyne J.C. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: A qualitative study. J Gen Intern Med 22 8 (2007) 1094-1100
10. Simon G.E., and Ludman E.J. Outcome of new benzodiazepine prescriptions to older adults in primary care. Gen Hosp Psychiatry 28 (2006) 374-378
11. Cook J.M., Marshall R., Masci C., and Coyne J.C. Physician perspectives on benzodiazepine prescription to older adults: A qualitative study. JGIM 22 (2007) 303-307
12. Baillargeon L., Landreville P., Verreault R., et al. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: A randomized trial. CMAJ 169 (2003) 1015-1020
13. Barter G., and Cormack M. The long-term use of benzodiazepines: patients views, accounts and experiences. Fam Pract 13 (1996) 491-497
14. Iliffe S., Curran H.V., Collins R., et al. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health 8 (2004) 242-248
15. King M.B., Gabe J., Williams P., and Rodrigo E.K. Long-term use of benzodiazepines: the views of patients. B J Gen Pract 40 (1990) 194-196
16. Tyrer P., Rutherford D., and Huggett T. Benzodiazepine withdrawal symptoms and propanolol. Lancet i (1981) 520-552
17. Wright N., Caplan R., and Payne S. Community survey of long term daytime use of benzodiazepines. BMJ 309 (1994) 27-28
18. Linden M., Bar T., and Geiselmann B. Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions. Psychol Med 28 (1998) 721-729
19. Bruce T.J., Spiegel D.A., Gregg S.F., and Nuzzarello A. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. Am J Psychiatry 152 (1995) 1156-1160
20. Bruce T.J., Spiegel D.A., and Hegel M.T. Cognitive-behavioral therapy helps prevent relapse and recurrent of panic disorder following alprazolam discontinuation: A long term follow-up of the Peoria and Dartmouth studies. J Consult Clin Psychol 67 (1999) 151-156
21. Spiegel D.A. Psychological strategies for discontinuing benzodiazepine treatment. J Clin Psychopharmacol 19 Suppl 2 (1999) 17S-22S
22. Katzman R., Brown T., Fuld P., et al. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry 140 (1983) 734-739
23. Sandelowski M. Combining qualitative and quantitative sampling, data collection, and analysis techniques in mixed-method studies. Res Nurs Health 23 (2000) 246-255
24. Radloff L.S. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1 (1977) 385-401
25. Beck A.T., Epstein N., Brown G., and Steer R.A. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 56 (1988) 893-897
26. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., and Kupfer D.J. The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Res 28 (1989) 193-213
27. Gossop M., Darke S., Grifiths P., et al. The severity of dependence scale (SDS) in English and Australian samples of heroin, cocaine, and amphetamine users. Addiction 90 (1995) 607-614
28. De Las Cuevas C., Sanz E.J., De La Fuente J.A., Padilla J., and Berenguer J.C. The severity of dependence scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 95 (2000) 245-250
29. Reiss S., Peterson R.A., Gursky D.M., and McNally R.J. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24 (1986) 1-8
30. Valenstein M., Taylor K.K., and Austin K. Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry 161 (2004) 654-661
31. Isacson D. Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time 13-year follow-up in a Swedish community. Soc Sci Med 44 (1997) 1871-1880
32. Stewart S.H., and Kushner M.G. Introduction to the special issue on anxiety sensitivity and addictive behaviors. Addict Behav 26 (2001) 775-785
33. Holton A., Riley P., and Tyrer P. Factors predicting long-term outcome after chronic benzodiazepine therapy. J Affect Disord 24 (1992) 245-252
34. Oude Voshaar R.C., Gorgels W.J., Mol A.J., et al. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program. Can J Psychiatry 51 (2006) 445-452
35. Schweizer E., Rickels R., De Martinis N., Case G., and Garcia-Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychol Med 28 (1998) 713-720
36. Oude Voshaar R.C., Couvée J.E., Van Balkom A.J.L.M., and Zitman F.G. Strategies to discontinue long-term benzodiazepine use: a meta-analysis. Br J Psychiatry 189 (2006) 213-220
37. Voyer P., Cappeliez P., Pérodeau G., and Préville M. Mental health for older adults and benzodiazepine use. J Community Health Nurs 22 (2005) 213-229